Applied therapeutics, inc. announces offering of 3,000,000 shares of common stock

New york, feb. 10, 2021 (globe newswire) -- applied therapeutics, inc. (nasdaq: aplt) (the “company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it plans to make a public offering of 3,000,000 shares of its common stock, par value $0.0001 per share, in an underwritten registered public offering. the company expects to grant the underwriters a 30-day option to purchase up to 450,000 additional shares of its common stock.
APLT Ratings Summary
APLT Quant Ranking